| Log in

Company watch: Concord Biotech eyes new opportunities after Quadria’s backing

04 September, 2017

Biotechnologist Sudhir Vaid quit drugmaker Ranbaxy Laboratories Ltd exactly 20 years ago to start his entrepreneurial journey. The Ahmedabad-based biotechnology company that he lat ....

To read the Full Story

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
Rakesh Jhunjhunwala-backed Concord Biotech looking to enter biosimilars market

Rakesh Jhunjhunwala-backed Concord Biotech looking to enter biosimilars market

Lohit Jagwani 4 years ago
Ahmedabad-based bulk drug maker Concord Biotech Ltd is in talks with strategic...
Exclusive: Quadria invests in Rakesh Jhunjhunwala-backed Concord Biotech

Exclusive: Quadria invests in Rakesh Jhunjhunwala-backed Concord Biotech

Joseph Rai 2 years ago
India and Southeast Asia-focused healthcare private equity firm Quadria Capital...
Sun Pharma shares fall over US FDA warning on Halol plant

Sun Pharma shares fall over US FDA warning on Halol plant

Joseph Rai 2 years ago
Shares of Sun Pharmaceutical Industries Ltd fell as much as 7.5 per cent on...
No Comments

Company watch: Concord Biotech eyes new opportunities after Quadria’s backing

Powered by WordPress.com VIP